articleTop 1% cited

HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial

Breast Cancer Research and Treatment · 2010 · Vol. 124(2) · pp. 403–412

Tanja Fehm✉(University of Tübingen)Volkmar Müller(Universität Hamburg)Bahriye Aktas(Essen University Hospital)Wolfgang Janni(Düsseldorf University Hospital)Andreas Schneeweiß(Heidelberg University)Elmar Stickeler(University of Freiburg)Claus Lattrich(Caritas-Krankenhaus St. Josef)Christian Löhberg(Friedrich-Alexander-Universität Erlangen-Nürnberg)Erich Solomayer(Universitätsklinikum des Saarlandes)Brigitte Rack(München Klinik)Sabine Riethdorf(Universität Hamburg)Christoph A. Klein(University of Regensburg)Christian Schindlbeck(München Klinik)Kerstin A. Brocker(Heidelberg University)Sabine Kasimir‐Bauer(Essen University Hospital)D. Wallwiener(University of Tübingen)Klaus Pantel(University Medical Center Hamburg-Eppendorf)

View via DOI Publisher page

Cancer Cells and Metastasis HER2/EGFR in Cancer Research Cancer Genomics and DiagnosticsMedicineCirculating tumor cellBreast cancerOncologyInternal medicineMetastatic breast cancerContext (archaeology)CancerProspective cohort studyClinical trial

MeSH terms

Breast NeoplasmsFemaleFluorescent Antibody TechniqueGermanyHumansNeoplastic Cells, CirculatingPredictive Value of TestsProspective StudiesReagent Kits, DiagnosticRNA, NeoplasmTime FactorsBiomarkers, TumorTreatment OutcomeDisease-Free SurvivalErb-b2 Receptor Tyrosine Kinases

Citations

356

FWCI

14.08

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

References

Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System